raloxifene hydrochloride has been researched along with palmitic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliaga, C; Calcagnotto, A; El-Bayoumy, K; Manni, A; Richie, JP; Schetter, SE; Trushin, N | 1 |
| Bhatia, S; Kamboj, S; Rana, V; Sethi, S | 1 |
1 trial(s) available for raloxifene hydrochloride and palmitic acid
| Article | Year |
|---|---|
Stearoyl-CoA desaturase-1, a novel target of omega-3 fatty acids for reducing breast cancer risk in obese postmenopausal women.
Topics: Adult; Aged; Biomarkers; Body Mass Index; Breast Density; Breast Neoplasms; Docosahexaenoic Acids; Dose-Response Relationship, Drug; Drug Combinations; Eicosapentaenoic Acid; Estrogen Receptor Modulators; Fatty Acids; Fatty Acids, Monounsaturated; Fatty Acids, Omega-3; Female; Follow-Up Studies; Humans; Middle Aged; Obesity; Oleic Acid; Palmitic Acid; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Stearoyl-CoA Desaturase | 2017 |
1 other study(ies) available for raloxifene hydrochloride and palmitic acid
| Article | Year |
|---|---|
Exploring the feasibility of carbamoylethyl pullulan-g-palmitic acid polymeric micelles for the effective targeting of raloxifene to breast tumor: Optimization and preclinical evaluation.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Feasibility Studies; Glucans; Micelles; Palmitic Acid; Particle Size; Polymers; Raloxifene Hydrochloride; Rats; Tissue Distribution | 2021 |